Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Life Tables

Life Tables

A life table is a statistical tool that summarizes the mortality and survival patterns of a population, providing detailed insights into the likelihood of survival or death across different age intervals within a cohort. By organizing data on survival probabilities and mortality rates, life tables offer a clear snapshot of population dynamics over time. They are extensively used in demography, public health, actuarial science, and ecology to analyze life expectancy, design health interventions,...

Barrett Esophagus-I: Introduction

Barrett Esophagus-I: Introduction

Barrett's esophagus is a medical condition where the esophageal mucosa is significantly damaged by stomach acid or other digestive fluids, often due to long-term exposure associated with gastroesophageal reflux disease (GERD). In GERD, a weakened or abnormally relaxed lower esophageal sphincter allows stomach acid to flow persistently into the esophagus.
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...

Kaplan-Meier Approach

Kaplan-Meier Approach

The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...

COPD: Pathogenesis and Clinical Features

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Evaluation of therapeutic plasma exchange in anti-neutrophil cytoplasmic antibody-associated vasculitis in real-life settings: long-term results of propensity score matching analysis in high-risk patients.

Scandinavian journal of rheumatology·2025

Same author

Correction: Corneal sensitivity and subjective complaints of ocular pain in patients with fibromyalgia.

Eye (London, England)·2024

Same author

Apremilast to treat oral ulcers in Behçet syndrome.

Drugs of today (Barcelona, Spain : 1998)·2020

Same author

Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.

Lupus·2020

Same author

Predictive Value of Interleukin 2 and Interleukin 8 on Early Rejection in Living Related Kidney Transplant Recipients.

Transplantation proceedings·2019

Same author

Panel Reactive Antibody Responses Against Influenza Vaccination in Kidney Transplant Recipients.

Transplantation proceedings·2019

Search research articles

Related Experiment Videos

Mortality in Behçet's syndrome.

H Yazici¹, F Esen

¹Division of Rheumatology, Cerrahpaşa Medical Faculty, University of Istanbul, Istanbul, Turkey. hyazici@attglobal.net

Clinical and Experimental Rheumatology

|December 17, 2008

Summary

This summary is machine-generated.

Behçet's syndrome poses a higher mortality risk, particularly in young males, mainly due to pulmonary artery aneurysms (PAA). However, mortality has decreased with earlier recognition and treatment of this rare vascular disease.

Related Experiment Videos

Area of Science:

Rheumatology
Vascular Medicine
Internal Medicine

Background:

Behçet's syndrome is a rare, chronic inflammatory disease affecting multiple organ systems.
Mortality is significantly higher in young males, primarily due to vascular complications.
The disease course often shows improvement over time, with varying severity based on demographics.

Purpose of the Study:

To analyze mortality patterns and causes in Behçet's syndrome.
To investigate the role of atherosclerosis and vascular disease in patient outcomes.
To highlight recent improvements in managing life-threatening complications.

Main Methods:

Review of patient data and mortality statistics.
Analysis of causes of death, focusing on vascular events.
Comparison of atherosclerosis prevalence with other inflammatory conditions.

Main Results:

The primary cause of mortality is large vessel disease, specifically bleeding pulmonary artery aneurysms (PAA) in males.
Central nervous system disease is the second leading cause of death.
Atherosclerosis and related events like angina or myocardial infarction are not significantly increased compared to other inflammatory diseases.
Intermittent claudication is linked to venous disease, not arterial issues.
Prompt recognition and treatment have led to a substantial decrease in PAA-related mortality.

Conclusions:

Behçet's syndrome carries a significant mortality risk, especially from PAA in young males.
Vascular complications, particularly PAA, are the main drivers of mortality.
Atherosclerosis is not a major concern in Behçet's syndrome; venous disease can cause claudication.
Improved diagnostic and treatment strategies have positively impacted survival rates for PAA.